SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-267705
Filing Date
2023-11-01
Accepted
2023-11-01 07:15:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d527979ddefa14a.htm DEFA14A 72978
2 GRAPHIC g527979g1101113455835.jpg GRAPHIC 4962
  Complete submission text file 0001193125-23-267705.txt   80938
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39219 | Film No.: 231366553
SIC: 2836 Biological Products, (No Diagnostic Substances)